Company intelligence / Profile preview

ToxStrategies

Katy, Texas, United Statestoxstrategies.com ↗

Ownership: Private
Development stage: Other

Overview

ToxStrategies provides multidisciplinary scientific consulting services specializing in toxicology, epidemiology, exposure sciences, industrial hygiene and safety, regulatory compliance and health economics. The company assists life science clients with nonclinical toxicology study design and management for drug development from discovery through regulatory submission. It does not develop its own therapeutics or conduct proprietary clinical trials. Recent acquisitions include Clintrex Research Corporation (CNS clinical/regulatory consulting) and Modality Solutions (biopharma cold chain logistics).

Therapeutic areas: Psychiatry
Modalities: small moleculesbiologicsbiosimilarsmedical devices
Industry: Consulting

Beyond the preview

Go deeper on ToxStrategies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ToxStrategies.

Explore the full profile